Results 231 to 240 of about 585,553 (296)

Anti‐NMDA receptor autoimmune encephalitis associated with ovarian teratoma: A case series and literature review

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 23-30, April 2025.
Abstract Autoimmune encephalitis is a group of disorders characterized by symptoms of dysfunction of the limbic and extra‐limbic systems that occur in association with antibodies against intracellular antigens, synapses, or proteins located on the surface of nerve cells. Anti‐NMDA (N‐methyl‐D‐aspartate) receptor encephalitis was first described in 2007
Pham Ba Nha   +6 more
wiley   +1 more source

A náusea e o mimeógrafo: os poetas estão nas ruas

open access: yesLetras de Hoje, 1983
Curvello, Aricy
doaj  

Artificial intelligence in obstetrics and gynecology: Evaluating ChatGPT and Google Gemini in answering patient questions

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Introduction To evaluate the accuracy and completeness of responses across common obstetrical and gynecologic topics generated by the large language models (LLMs) ChatGPT and Google Gemini, which have become increasingly popular for patients seeking medical information before physician consultations.
Madeline West   +6 more
wiley   +1 more source

Physical agents' level in women with primary dysmenorrhea: A cross‐sectional observational study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Primary dysmenorrhea (PD), menstrual pain in the absence of pathology, is the main reason for gynecological consultation in young women. Physical agents, used in physiotherapy for therapeutic purposes, can be self‐used by women with primary dysmenorrhea.
Zeltia Naia, Olalla Bello
wiley   +1 more source

Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum‐resistant ovarian cancer: Phase I expansion results

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective In the dose‐escalation part of Study 101, which included multiple tumor types, objective responses were observed in 10 of 22 patients across multiple dose levels of farletuzumab ecteribulin (FZEC). We explored the safety/antitumor activity of FZEC in patients with platinum‐resistant ovarian cancer (PROC) from the Study 101 expansion ...
Kan Yonemori   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy